Skip to main content

Talphera, Inc.

TLPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427925

No open-market purchases or sales by Talphera, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $24.6M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Talphera, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of TLPH: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders32127−4
Shares1.10M3.17K1.06M−38.2K (−3.5%)
Value$720.9K$2.09K$1.17M+$451.7K (+62.8%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Talphera, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to TLPH in Q2 2023
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP16,658$18.5K0.00%
Barclays PLC217$2410.00%
WealthPlan Investment Management, LLC75$830.00%

Sold out (7)

Institutions that held Talphera, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Not filed for Q2 2023 yet (1)

Institutions that held Talphera, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TLPH in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Ahrens Investment Partners LLC3,175$2.09K